Why Physicians Are Optimistic about Newly Diagnosed Myeloma
Why Physicians Are Optimistic about Newly Diagnosed Myeloma  image
Feb 18, 2021 / 11:00AM - 12:00PM MST
Newly Diagnosed Myeloma Patients Chapter

Event Description

Fear, uncertainty, and pessimism accompany virtually every cancer diagnosis, especially if most patients, like those with myeloma, have never even heard the word before. Yet myeloma specialists are increasingly confident and optimistic that the vast majority of diagnosed patients have legitimate paths toward longevity, good quality of life, and will benefit from increasing treatment options and experience. Join us as we review the Myeloma Crowd Round Table featuring Multiple Myeloma Specialists. After we review the MCRT, Dr. Sarah Lee will serve as our moderator for a Q&A. Come with questions! This is a Google Meet Meeting. You can join even if you don't have a Gmail Account. If you are joining via mobile, please make sure you have the Google Meet App downloaded.

Schedule & Agenda

person
Introductions
11:00AM
Audrey Burton-Bethke
Audrey Burton-Bethke, Manager of the Myeloma Community, introduces the agenda of the event and Dr. Sarah Lee who will moderate our Q&A. 
person
Presentation: Why Physicians are Optimistic about Newly Diagnosed Myeloma
11:05AM
Myeloma Crowd Round Table
Watch portions of the Myeloma Crowd Round Table session and hear from multiple myeloma specialists about why they are optimistic about newly diagnosed myeloma. 
person
Questions and Answers
11:35AM
Sarah Lee, MD
Dr. Sarah Lee will moderate our Q&A. What questions did the MCRT spark for you? What other questions do you have? 

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the Myeloma Crowd as the Community Manager in 2020 after previously working in the nonprofit field for 4 years as a director of Fundraising and Development. She graduated from BYU with a major in Spanish and Nonprofit Management. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Sarah Lee, MD
Sarah Lee, MD

Dr. Lee is a hematologist-oncologist who specializes in the care of patients with plasma cell disorders. Before joining SCCA, she completed a fellowship in hematology-oncology at the Cleveland Clinic. Her background also includes experience in researching novel therapies for multiple myeloma, amyloidosis, and other plasma cell disorders. What drew her to SCCA was the opportunity to participate in clinical research and to embrace a collaborative approach to medicine.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

+1 800 709 1113

email

Support@healthtree.org

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Legend Biotechnologies
Bristol Myers Squibb
Abbvie
Genentech
GSK
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation for Multiple Myeloma (formerly know as Myeloma Crowd) is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811